Brawn Biotech Other Announcement
Brawn Biotech declared related party transaction filing under Regulation 23(9) non-applicable for FY 2025-26. Its paid-up capital and net worth are below the exemption thresholds.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Brawn Biotech declared related party transaction filing under Regulation 23(9) non-applicable for FY 2025-26. Its paid-up capital and net worth are below the exemption thresholds.
Brawn Biotech Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026. The filing includes details on promoter and public shareholding.
Brawn Biotech Ltd members approved the appointment of M/s. GDSM and Co. as Statutory Auditors. Mr. Brij Raj Gupta was also re-appointed as Director at the Annual General Meeting.
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
Brawn Biotech Ltd notified BSE regarding the non-applicability of Regulation 24A for Annual Secretarial Compliance Report. The company remains below the mandatory reporting thresholds for capital and networth.